

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.37179557 |
| 2 | muscle filament sliding (GO:0030049) | 7.17978337 |
| 3 | actin-myosin filament sliding (GO:0033275) | 7.17978337 |
| 4 | cardiac myofibril assembly (GO:0055003) | 6.89556542 |
| 5 | myofibril assembly (GO:0030239) | 6.25166481 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.16717996 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.86453100 |
| 8 | plasma membrane repair (GO:0001778) | 5.76762351 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 5.64226836 |
| 10 | actomyosin structure organization (GO:0031032) | 5.09152333 |
| 11 | cardiac muscle cell development (GO:0055013) | 5.04984634 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.01174288 |
| 13 | cardiac muscle contraction (GO:0060048) | 4.99091568 |
| 14 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.96374112 |
| 15 | actin filament-based movement (GO:0030048) | 4.88561016 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 4.86034953 |
| 17 | cardiac cell development (GO:0055006) | 4.84659978 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.75591159 |
| 19 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.72441061 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.58842722 |
| 21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.55470140 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 4.49434901 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 4.36081247 |
| 24 | muscle tissue morphogenesis (GO:0060415) | 4.30283460 |
| 25 | striated muscle hypertrophy (GO:0014897) | 4.29697016 |
| 26 | tricarboxylic acid cycle (GO:0006099) | 4.22311272 |
| 27 | carnitine shuttle (GO:0006853) | 4.18664979 |
| 28 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.16433249 |
| 29 | striated muscle contraction (GO:0006941) | 4.12902674 |
| 30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.12399076 |
| 31 | heart trabecula formation (GO:0060347) | 4.11795760 |
| 32 | regulation of sarcomere organization (GO:0060297) | 4.03526675 |
| 33 | muscle hypertrophy (GO:0014896) | 3.91659023 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 3.88175837 |
| 35 | heart contraction (GO:0060047) | 3.87101504 |
| 36 | heart process (GO:0003015) | 3.87101504 |
| 37 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.85225108 |
| 38 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.83458000 |
| 39 | cell communication by electrical coupling (GO:0010644) | 3.80743865 |
| 40 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.77451540 |
| 41 | adult heart development (GO:0007512) | 3.75863503 |
| 42 | response to inactivity (GO:0014854) | 3.65376790 |
| 43 | negative regulation of protein localization to cell surface (GO:2000009) | 3.64381817 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 3.61621320 |
| 45 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.59317082 |
| 46 | regulation of cardioblast differentiation (GO:0051890) | 3.57728868 |
| 47 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.54750338 |
| 48 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.54430306 |
| 49 | regulation of cell communication by electrical coupling (GO:0010649) | 3.49248561 |
| 50 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.48766851 |
| 51 | relaxation of muscle (GO:0090075) | 3.38920187 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.38492529 |
| 53 | regulation of the force of heart contraction (GO:0002026) | 3.36162493 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.29474847 |
| 55 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.28823208 |
| 56 | muscle contraction (GO:0006936) | 3.16302768 |
| 57 | regulation of sequestering of triglyceride (GO:0010889) | 3.16259348 |
| 58 | desmosome organization (GO:0002934) | 3.14987296 |
| 59 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.07441079 |
| 60 | cell adhesion mediated by integrin (GO:0033627) | 3.07287183 |
| 61 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.05371338 |
| 62 | carnitine transmembrane transport (GO:1902603) | 3.04333030 |
| 63 | skeletal muscle contraction (GO:0003009) | 3.03919478 |
| 64 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.03578998 |
| 65 | trabecula formation (GO:0060343) | 3.03502448 |
| 66 | regulation of muscle system process (GO:0090257) | 3.03239494 |
| 67 | muscle hypertrophy in response to stress (GO:0003299) | 3.03113970 |
| 68 | cardiac muscle adaptation (GO:0014887) | 3.03113970 |
| 69 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.03113970 |
| 70 | muscle fiber development (GO:0048747) | 3.01822894 |
| 71 | striated muscle cell development (GO:0055002) | 3.01815970 |
| 72 | response to caffeine (GO:0031000) | 3.01368126 |
| 73 | muscle cell cellular homeostasis (GO:0046716) | 3.00854774 |
| 74 | skeletal muscle adaptation (GO:0043501) | 2.98677628 |
| 75 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.98255125 |
| 76 | ventricular cardiac muscle cell development (GO:0055015) | 2.98039724 |
| 77 | cardiac chamber formation (GO:0003207) | 2.97909166 |
| 78 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.97024419 |
| 79 | regulation of heart contraction (GO:0008016) | 2.96831130 |
| 80 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.96478842 |
| 81 | muscle system process (GO:0003012) | 2.95935848 |
| 82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90800534 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 2.90066468 |
| 84 | creatine metabolic process (GO:0006600) | 2.89539153 |
| 85 | striated muscle adaptation (GO:0014888) | 2.87268350 |
| 86 | atrial septum morphogenesis (GO:0060413) | 2.87082369 |
| 87 | response to epinephrine (GO:0071871) | 2.85107228 |
| 88 | regulation of cofactor metabolic process (GO:0051193) | 2.84883867 |
| 89 | regulation of coenzyme metabolic process (GO:0051196) | 2.84883867 |
| 90 | atrioventricular valve morphogenesis (GO:0003181) | 2.82507986 |
| 91 | negative regulation of heart growth (GO:0061117) | 2.82072006 |
| 92 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.82072006 |
| 93 | regulation of p38MAPK cascade (GO:1900744) | 2.81046461 |
| 94 | relaxation of cardiac muscle (GO:0055119) | 2.78903405 |
| 95 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.78638947 |
| 96 | adrenergic receptor signaling pathway (GO:0071875) | 2.78205194 |
| 97 | cellular response to epinephrine stimulus (GO:0071872) | 2.77023960 |
| 98 | regulation of cardiac muscle contraction (GO:0055117) | 2.76839551 |
| 99 | amino-acid betaine transport (GO:0015838) | 2.76459516 |
| 100 | carnitine transport (GO:0015879) | 2.76459516 |
| 101 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.76445928 |
| 102 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.75895882 |
| 103 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.75895882 |
| 104 | regulation of tight junction assembly (GO:2000810) | 2.75682619 |
| 105 | positive regulation of heart rate (GO:0010460) | 2.75415604 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 2.74685762 |
| 107 | regulation of muscle contraction (GO:0006937) | 2.71664102 |
| 108 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70791783 |
| 109 | regulation of ATP catabolic process (GO:1903289) | 2.69772947 |
| 110 | regulation of ATPase activity (GO:0043462) | 2.69772947 |
| 111 | cardiac conduction (GO:0061337) | 2.69068091 |
| 112 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66768825 |
| 113 | regulation of fatty acid oxidation (GO:0046320) | 2.66494032 |
| 114 | skeletal muscle tissue development (GO:0007519) | 2.65622930 |
| 115 | gap junction assembly (GO:0016264) | 2.64408147 |
| 116 | response to muscle activity (GO:0014850) | 2.63502120 |
| 117 | regulation of myoblast differentiation (GO:0045661) | 2.63334891 |
| 118 | muscle cell development (GO:0055001) | 2.62765391 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.62606840 |
| 120 | positive regulation of cation channel activity (GO:2001259) | 2.60929734 |
| 121 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.60566454 |
| 122 | endocardial cushion development (GO:0003197) | 2.57748018 |
| 123 | muscle adaptation (GO:0043500) | 2.56860787 |
| 124 | cardiac muscle cell action potential (GO:0086001) | 2.56784832 |
| 125 | cell-substrate junction assembly (GO:0007044) | 2.56159672 |
| 126 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.56042507 |
| 127 | regulation of heart rate (GO:0002027) | 2.55397061 |
| 128 | positive regulation of heart contraction (GO:0045823) | 2.55349506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.78539269 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66131122 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.44069449 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.99548861 |
| 5 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.71217585 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.13021321 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.96378539 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.96155767 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92745736 |
| 10 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.80529071 |
| 11 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.80529071 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64324830 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63729357 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.37583743 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.30817806 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.28878087 |
| 17 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.28251805 |
| 18 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.20322486 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.15045880 |
| 20 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.12010887 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.09673720 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.07941399 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.05346859 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.02507558 |
| 25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01923887 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97046911 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96113457 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.88003854 |
| 29 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86672391 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86586078 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86373661 |
| 32 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.83558124 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82960260 |
| 34 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.81185408 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80251683 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79081619 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.77063278 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75066812 |
| 39 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74835818 |
| 40 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.74154720 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73585813 |
| 42 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.72442418 |
| 43 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.72442418 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72291994 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.72083523 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.72083523 |
| 47 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.72058856 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.69490637 |
| 49 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65144762 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64552371 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62310676 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58987153 |
| 53 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57287380 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54568918 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52419053 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52322218 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51329199 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50364523 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49695243 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49212179 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47063964 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.43975239 |
| 63 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.43738495 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43356811 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42188692 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.42146212 |
| 67 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.41981377 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38361422 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36285861 |
| 70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35607918 |
| 71 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.34885028 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34382422 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32990226 |
| 74 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31857559 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29799867 |
| 76 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29368993 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.29057834 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28786527 |
| 79 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.28155769 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26644713 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.25444927 |
| 82 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25011119 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24820197 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24311160 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24259315 |
| 86 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21347269 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20862211 |
| 88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19038430 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18470109 |
| 90 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18435879 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16855018 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16576769 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16163633 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15046904 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14722211 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14285139 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14154531 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13439815 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12441373 |
| 100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11857616 |
| 101 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11654764 |
| 102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11328089 |
| 103 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09970581 |
| 104 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09764982 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08684795 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08466094 |
| 107 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08413998 |
| 108 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07932114 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07426154 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07302890 |
| 111 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.06490716 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06282422 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05920259 |
| 114 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04804197 |
| 115 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04452997 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04087296 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03945818 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03389155 |
| 119 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03162014 |
| 120 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03042468 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02261560 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00745516 |
| 123 | P300_19829295_ChIP-Seq_ESCs_Human | 0.99299813 |
| 124 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99273094 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99127245 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98995027 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98935597 |
| 128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98710730 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98570046 |
| 130 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98306084 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97734799 |
| 132 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97381358 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97098968 |
| 134 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96947209 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96897484 |
| 136 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96867195 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95531846 |
| 138 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95492288 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95177258 |
| 140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93299445 |
| 141 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92176781 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91959715 |
| 143 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91090154 |
| 144 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89325414 |
| 145 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87217930 |
| 146 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86025326 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83635992 |
| 148 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83528237 |
| 149 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83418192 |
| 150 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.83262392 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82846190 |
| 152 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82232775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 4.62219449 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.88769411 |
| 3 | MP0000749_muscle_degeneration | 3.75303777 |
| 4 | MP0000751_myopathy | 3.68912700 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.36992797 |
| 6 | MP0003646_muscle_fatigue | 3.27224525 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.23819224 |
| 8 | MP0005330_cardiomyopathy | 3.18964443 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.06946121 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.82228609 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.67256791 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.57722667 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.57653711 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.56223638 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.41142973 |
| 16 | MP0005275_abnormal_skin_tensile | 2.40861241 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.39276800 |
| 18 | MP0004130_abnormal_muscle_cell | 2.25598791 |
| 19 | MP0003279_aneurysm | 2.23747362 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.18258826 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.18258826 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.15897146 |
| 23 | MP0003828_pulmonary_edema | 2.13146705 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.11671266 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.09083810 |
| 26 | MP0006138_congestive_heart_failure | 2.05457415 |
| 27 | MP0002269_muscular_atrophy | 2.00631343 |
| 28 | MP0004484_altered_response_of | 2.00054657 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.99858197 |
| 30 | MP0004510_myositis | 1.88755468 |
| 31 | MP0004272_abnormal_basement_membrane | 1.87612697 |
| 32 | MP0000747_muscle_weakness | 1.86624509 |
| 33 | MP0005369_muscle_phenotype | 1.83278765 |
| 34 | MP0000759_abnormal_skeletal_muscle | 1.80739771 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.77034419 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.71439400 |
| 37 | MP0005503_abnormal_tendon_morphology | 1.66983451 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.59771125 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.57976324 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55172683 |
| 41 | MP0000733_abnormal_muscle_development | 1.41874765 |
| 42 | MP0001661_extended_life_span | 1.39100407 |
| 43 | MP0004085_abnormal_heartbeat | 1.37144150 |
| 44 | MP0004233_abnormal_muscle_weight | 1.36139805 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.33475661 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.30944214 |
| 47 | MP0000343_altered_response_to | 1.30612830 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.29581681 |
| 49 | MP0001958_emphysema | 1.29477307 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.29254720 |
| 51 | MP0000767_abnormal_smooth_muscle | 1.29242134 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.23998015 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.23871248 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.19567123 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16684431 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.13653072 |
| 57 | MP0000266_abnormal_heart_morphology | 1.13233136 |
| 58 | MP0002128_abnormal_blood_circulation | 1.10107946 |
| 59 | MP0003091_abnormal_cell_migration | 1.08170872 |
| 60 | MP0006054_spinal_hemorrhage | 1.04689747 |
| 61 | MP0005165_increased_susceptibility_to | 1.03925052 |
| 62 | MP0005023_abnormal_wound_healing | 0.97858543 |
| 63 | MP0005187_abnormal_penis_morphology | 0.96232393 |
| 64 | MP0003941_abnormal_skin_development | 0.94730217 |
| 65 | MP0005670_abnormal_white_adipose | 0.94546837 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 0.94401283 |
| 67 | MP0000762_abnormal_tongue_morphology | 0.94119317 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 0.91493660 |
| 69 | MP0005375_adipose_tissue_phenotype | 0.89731740 |
| 70 | MP0002060_abnormal_skin_morphology | 0.82273352 |
| 71 | MP0000462_abnormal_digestive_system | 0.80759802 |
| 72 | MP0010030_abnormal_orbit_morphology | 0.80157947 |
| 73 | MP0002925_abnormal_cardiovascular_devel | 0.78718572 |
| 74 | MP0001614_abnormal_blood_vessel | 0.78718348 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.77689726 |
| 76 | MP0003045_fibrosis | 0.77668375 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.76527910 |
| 78 | MP0000013_abnormal_adipose_tissue | 0.74673585 |
| 79 | MP0005248_abnormal_Harderian_gland | 0.73856434 |
| 80 | MP0000534_abnormal_ureter_morphology | 0.72234930 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.72110447 |
| 82 | MP0005171_absent_coat_pigmentation | 0.68802779 |
| 83 | MP0004134_abnormal_chest_morphology | 0.66824046 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.66428421 |
| 85 | MP0005257_abnormal_intraocular_pressure | 0.64717111 |
| 86 | MP0002971_abnormal_brown_adipose | 0.63181933 |
| 87 | MP0005508_abnormal_skeleton_morphology | 0.62356030 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.61820450 |
| 89 | MP0003252_abnormal_bile_duct | 0.61484093 |
| 90 | MP0000249_abnormal_blood_vessel | 0.56605470 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.56583461 |
| 92 | MP0003385_abnormal_body_wall | 0.55778176 |
| 93 | MP0005451_abnormal_body_composition | 0.55745401 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.55741896 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.55191372 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.53167123 |
| 97 | MP0003136_yellow_coat_color | 0.52968591 |
| 98 | MP0009840_abnormal_foam_cell | 0.52898634 |
| 99 | MP0004043_abnormal_pH_regulation | 0.52505484 |
| 100 | MP0005409_darkened_coat_color | 0.52423912 |
| 101 | MP0001784_abnormal_fluid_regulation | 0.52206222 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.51377345 |
| 103 | MP0002168_other_aberrant_phenotype | 0.51367336 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.51245461 |
| 105 | MP0003984_embryonic_growth_retardation | 0.51161297 |
| 106 | MP0009250_abnormal_appendicular_skeleto | 0.49800883 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.49798781 |
| 108 | MP0001243_abnormal_dermal_layer | 0.49301198 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.48843930 |
| 110 | MP0000579_abnormal_nail_morphology | 0.48761600 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.48199160 |
| 112 | MP0002933_joint_inflammation | 0.48150696 |
| 113 | MP0009053_abnormal_anal_canal | 0.47614349 |
| 114 | MP0005266_abnormal_metabolism | 0.46560966 |
| 115 | MP0003755_abnormal_palate_morphology | 0.46515700 |
| 116 | MP0005085_abnormal_gallbladder_physiolo | 0.44697479 |
| 117 | MP0005388_respiratory_system_phenotype | 0.44271388 |
| 118 | MP0002133_abnormal_respiratory_system | 0.44271388 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.41994505 |
| 120 | MP0001853_heart_inflammation | 0.41907382 |
| 121 | MP0000163_abnormal_cartilage_morphology | 0.38757807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.15927948 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.89997983 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.58206051 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.34938854 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.19710226 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 5.17332960 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.16864189 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 5.09455845 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.95152653 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 4.69834065 |
| 11 | Atrial fibrillation (HP:0005110) | 4.63826443 |
| 12 | Increased connective tissue (HP:0009025) | 4.55757255 |
| 13 | Lipoatrophy (HP:0100578) | 4.52697121 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 4.28851300 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.26084746 |
| 16 | Myoglobinuria (HP:0002913) | 4.22267412 |
| 17 | Subaortic stenosis (HP:0001682) | 4.15146436 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.15146436 |
| 19 | Supraventricular tachycardia (HP:0004755) | 4.08286341 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 4.06598994 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.06049201 |
| 22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.05538922 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 4.04324199 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 3.63342773 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.62368871 |
| 26 | Nemaline bodies (HP:0003798) | 3.45815604 |
| 27 | Difficulty running (HP:0009046) | 3.43755812 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.42738890 |
| 29 | Rhabdomyolysis (HP:0003201) | 3.42721478 |
| 30 | Protrusio acetabuli (HP:0003179) | 3.32432261 |
| 31 | Syncope (HP:0001279) | 3.24686678 |
| 32 | Ventricular arrhythmia (HP:0004308) | 3.17713266 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.16454843 |
| 34 | Difficulty climbing stairs (HP:0003551) | 3.03740988 |
| 35 | Palpitations (HP:0001962) | 2.98977806 |
| 36 | Round ear (HP:0100830) | 2.91511320 |
| 37 | Bundle branch block (HP:0011710) | 2.90136385 |
| 38 | Prolonged QT interval (HP:0001657) | 2.84667259 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.70752769 |
| 40 | Abnormal atrioventricular conduction (HP:0005150) | 2.69906799 |
| 41 | Myotonia (HP:0002486) | 2.68021948 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.63474833 |
| 43 | Neck muscle weakness (HP:0000467) | 2.63225844 |
| 44 | Heart block (HP:0012722) | 2.61592848 |
| 45 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60570749 |
| 46 | Atrioventricular block (HP:0001678) | 2.56801573 |
| 47 | Spinal rigidity (HP:0003306) | 2.56431594 |
| 48 | Scapular winging (HP:0003691) | 2.54232161 |
| 49 | Limited hip movement (HP:0008800) | 2.54009680 |
| 50 | Broad metatarsal (HP:0001783) | 2.51768284 |
| 51 | Muscle stiffness (HP:0003552) | 2.47977091 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.47755898 |
| 53 | Aortic dissection (HP:0002647) | 2.45326735 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.43123470 |
| 55 | Aortic aneurysm (HP:0004942) | 2.40705172 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.39936109 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.38457864 |
| 58 | Areflexia of lower limbs (HP:0002522) | 2.32189274 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.18572169 |
| 60 | Conjunctival hamartoma (HP:0100780) | 2.17306907 |
| 61 | Generalized muscle weakness (HP:0003324) | 2.17029437 |
| 62 | Arterial tortuosity (HP:0005116) | 2.14759568 |
| 63 | Palmoplantar keratoderma (HP:0000982) | 2.12276879 |
| 64 | Muscular dystrophy (HP:0003560) | 2.11402339 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.08625581 |
| 66 | Calcaneovalgus deformity (HP:0001848) | 2.06957277 |
| 67 | Frequent falls (HP:0002359) | 2.06944930 |
| 68 | Atrophic scars (HP:0001075) | 2.06452223 |
| 69 | Vascular tortuosity (HP:0004948) | 2.06022775 |
| 70 | Facial diplegia (HP:0001349) | 2.05428483 |
| 71 | Aneurysm (HP:0002617) | 2.04354517 |
| 72 | Limb-girdle muscle atrophy (HP:0003797) | 2.03006353 |
| 73 | Rimmed vacuoles (HP:0003805) | 2.00350148 |
| 74 | Myopathic facies (HP:0002058) | 1.97626149 |
| 75 | Ankle contracture (HP:0006466) | 1.97246688 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 1.95436655 |
| 77 | Ulnar deviation of the wrist (HP:0003049) | 1.93445077 |
| 78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92346331 |
| 79 | Peritonitis (HP:0002586) | 1.87235720 |
| 80 | Ketoacidosis (HP:0001993) | 1.87004249 |
| 81 | Shallow orbits (HP:0000586) | 1.86798688 |
| 82 | Abnormal finger flexion creases (HP:0006143) | 1.86591322 |
| 83 | Deformed tarsal bones (HP:0008119) | 1.85783892 |
| 84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85682182 |
| 85 | Popliteal pterygium (HP:0009756) | 1.85341132 |
| 86 | Congestive heart failure (HP:0001635) | 1.84479822 |
| 87 | Sudden cardiac death (HP:0001645) | 1.84329045 |
| 88 | Gowers sign (HP:0003391) | 1.80338164 |
| 89 | Ventricular fibrillation (HP:0001663) | 1.78319040 |
| 90 | Bradycardia (HP:0001662) | 1.78188379 |
| 91 | Malignant hyperthermia (HP:0002047) | 1.75938552 |
| 92 | Hyperglycemia (HP:0003074) | 1.75902182 |
| 93 | Left ventricular hypertrophy (HP:0001712) | 1.75794115 |
| 94 | Hip contracture (HP:0003273) | 1.75740841 |
| 95 | Abnormal EKG (HP:0003115) | 1.75488910 |
| 96 | Dilatation of the ascending aorta (HP:0005111) | 1.74406356 |
| 97 | Fragile skin (HP:0001030) | 1.73847638 |
| 98 | Waddling gait (HP:0002515) | 1.73392339 |
| 99 | Absent phalangeal crease (HP:0006109) | 1.73279401 |
| 100 | Lymphangioma (HP:0100764) | 1.70724649 |
| 101 | Hyperkalemia (HP:0002153) | 1.70272089 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 1.69826772 |
| 103 | Steppage gait (HP:0003376) | 1.69163543 |
| 104 | Toxemia of pregnancy (HP:0100603) | 1.67932249 |
| 105 | EMG: neuropathic changes (HP:0003445) | 1.67539838 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.66991928 |
| 107 | Cervical subluxation (HP:0003308) | 1.66762737 |
| 108 | Neonatal death (HP:0003811) | 1.66756960 |
| 109 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.66034447 |
| 110 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65431314 |
| 111 | Proximal amyotrophy (HP:0007126) | 1.65129733 |
| 112 | Soft skin (HP:0000977) | 1.64417692 |
| 113 | Pulmonary artery stenosis (HP:0004415) | 1.63409927 |
| 114 | Aplasia of the musculature (HP:0100854) | 1.61746830 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.61053574 |
| 116 | Bulbar palsy (HP:0001283) | 1.60813027 |
| 117 | Abnormality of the neuromuscular junction (HP:0003398) | 1.59851226 |
| 118 | Fatigable weakness (HP:0003473) | 1.59851226 |
| 119 | Cardiovascular calcification (HP:0011915) | 1.56035644 |
| 120 | Slender build (HP:0001533) | 1.55111029 |
| 121 | Weak cry (HP:0001612) | 1.54669976 |
| 122 | Limb-girdle muscle weakness (HP:0003325) | 1.53797553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.69819806 |
| 2 | OBSCN | 5.68283796 |
| 3 | TRIB3 | 3.11371755 |
| 4 | PKN2 | 3.08711917 |
| 5 | DMPK | 2.92764057 |
| 6 | MYLK | 2.83710792 |
| 7 | PIK3CA | 2.58109530 |
| 8 | PHKG1 | 2.41849173 |
| 9 | PHKG2 | 2.41849173 |
| 10 | STK24 | 2.14325754 |
| 11 | LMTK2 | 2.07847030 |
| 12 | PDK3 | 2.01510011 |
| 13 | PDK4 | 2.01510011 |
| 14 | TRPM7 | 1.86418532 |
| 15 | ZAK | 1.86309874 |
| 16 | LATS1 | 1.72000608 |
| 17 | AKT3 | 1.57009809 |
| 18 | PDK2 | 1.54518400 |
| 19 | NEK9 | 1.51721294 |
| 20 | NEK1 | 1.51186493 |
| 21 | TIE1 | 1.45815874 |
| 22 | PIK3CG | 1.42480623 |
| 23 | PDGFRA | 1.41379147 |
| 24 | STK38L | 1.38713307 |
| 25 | RIPK1 | 1.37767476 |
| 26 | MAP2K3 | 1.36877342 |
| 27 | MAP3K3 | 1.34215168 |
| 28 | PAK3 | 1.33629222 |
| 29 | SIK1 | 1.31867963 |
| 30 | ILK | 1.22727023 |
| 31 | BCKDK | 1.20719679 |
| 32 | PTK6 | 1.09835075 |
| 33 | PNCK | 1.09152154 |
| 34 | ROCK1 | 1.06402002 |
| 35 | TGFBR2 | 1.05699983 |
| 36 | STK39 | 1.05625190 |
| 37 | DDR2 | 1.02360617 |
| 38 | EPHB2 | 1.01131290 |
| 39 | FLT3 | 1.00544427 |
| 40 | STK3 | 0.97861812 |
| 41 | PRKD1 | 0.97815840 |
| 42 | LRRK2 | 0.95530525 |
| 43 | LIMK1 | 0.95107715 |
| 44 | INSRR | 0.92595601 |
| 45 | KDR | 0.90236500 |
| 46 | MAP3K7 | 0.88935847 |
| 47 | ERN1 | 0.88889573 |
| 48 | FER | 0.87666260 |
| 49 | PAK2 | 0.86152193 |
| 50 | PRKAA2 | 0.84564624 |
| 51 | EPHB1 | 0.84401709 |
| 52 | MUSK | 0.77744901 |
| 53 | CDC42BPA | 0.76495545 |
| 54 | TESK1 | 0.75297242 |
| 55 | PRKCE | 0.74027131 |
| 56 | PTK2B | 0.72836406 |
| 57 | MAP3K5 | 0.71385031 |
| 58 | EPHA2 | 0.71321117 |
| 59 | LATS2 | 0.70883215 |
| 60 | PTK2 | 0.70221027 |
| 61 | CAMK2G | 0.69934082 |
| 62 | MET | 0.69466246 |
| 63 | BMX | 0.69372292 |
| 64 | MAPK12 | 0.68828747 |
| 65 | CAMK1 | 0.68325258 |
| 66 | STK4 | 0.67010782 |
| 67 | CAMK2D | 0.65807568 |
| 68 | MAPKAPK3 | 0.65665040 |
| 69 | JAK1 | 0.63811947 |
| 70 | NLK | 0.63271770 |
| 71 | MAPK7 | 0.62916636 |
| 72 | STK38 | 0.62354532 |
| 73 | STK10 | 0.62066374 |
| 74 | CAMK2A | 0.60834922 |
| 75 | BRSK2 | 0.59423158 |
| 76 | NME2 | 0.55588836 |
| 77 | DAPK3 | 0.55569467 |
| 78 | EPHA3 | 0.55318942 |
| 79 | PINK1 | 0.54879430 |
| 80 | FGFR3 | 0.53336602 |
| 81 | CAMK4 | 0.53319731 |
| 82 | FRK | 0.53293873 |
| 83 | PDGFRB | 0.52256400 |
| 84 | TBK1 | 0.51680152 |
| 85 | FGFR1 | 0.50065141 |
| 86 | ACVR1B | 0.48009586 |
| 87 | FGFR4 | 0.46739577 |
| 88 | MTOR | 0.46074204 |
| 89 | MARK1 | 0.44929059 |
| 90 | PRKG2 | 0.44862606 |
| 91 | ROCK2 | 0.44802696 |
| 92 | MST1R | 0.44797805 |
| 93 | PRKG1 | 0.44759440 |
| 94 | SGK3 | 0.44744274 |
| 95 | BMPR1B | 0.44637744 |
| 96 | SGK2 | 0.43677862 |
| 97 | CAMK1D | 0.43408448 |
| 98 | EEF2K | 0.41552601 |
| 99 | NUAK1 | 0.41233408 |
| 100 | GRK7 | 0.39703026 |
| 101 | ERBB4 | 0.38389216 |
| 102 | CAMK2B | 0.37890359 |
| 103 | TYK2 | 0.37802880 |
| 104 | WNK1 | 0.37714356 |
| 105 | MAP3K6 | 0.37640328 |
| 106 | WNK4 | 0.37058710 |
| 107 | RPS6KA4 | 0.36797866 |
| 108 | CAMK1G | 0.36126263 |
| 109 | MARK3 | 0.34936921 |
| 110 | MELK | 0.34197982 |
| 111 | GSK3A | 0.33933133 |
| 112 | PRKACG | 0.33293219 |
| 113 | MAP3K12 | 0.33210331 |
| 114 | * PRKAA1 | 0.33074617 |
| 115 | MAP3K10 | 0.31307608 |
| 116 | PRKACA | 0.30965202 |
| 117 | ADRBK1 | 0.30956624 |
| 118 | JAK3 | 0.30124787 |
| 119 | AKT2 | 0.30111977 |
| 120 | MAP2K1 | 0.30071388 |
| 121 | PAK4 | 0.29816255 |
| 122 | MOS | 0.29767565 |
| 123 | TNIK | 0.29332610 |
| 124 | TGFBR1 | 0.28626903 |
| 125 | ERBB3 | 0.27731550 |
| 126 | PKN1 | 0.27097627 |
| 127 | ABL2 | 0.27085914 |
| 128 | MAPK15 | 0.27058813 |
| 129 | CDK6 | 0.25612850 |
| 130 | MAP2K6 | 0.25608346 |
| 131 | RET | 0.24833080 |
| 132 | MAP2K4 | 0.22959984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.40468790 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.05708218 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.84003591 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.19884361 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.04385939 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.95824018 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67494085 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46980021 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37716901 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.06964134 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01564315 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 1.97404378 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94199084 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.92718687 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90434480 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86438204 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.61813048 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43157741 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.38002082 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36786718 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.31955702 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26201458 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.26143251 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25293978 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.23749322 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19013484 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18472343 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16273783 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.13601376 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13086878 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12256141 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10555562 |
| 33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.07949794 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07908152 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06386302 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.05975737 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00745226 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95945683 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93665341 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93057826 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91357332 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91211685 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90911737 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90679868 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89778285 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88128323 |
| 47 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86309091 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81743382 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 0.80731927 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80602561 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.79917593 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79759110 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78913944 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78757553 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77363777 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76606536 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75546944 |
| 58 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75493870 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.75424254 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73510639 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.72203534 |
| 62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70817005 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70034629 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69528035 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68494342 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67962908 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63808360 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63476553 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62661204 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62621087 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62545368 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59984211 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.59646008 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58217571 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58189179 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.57942801 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57875959 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57485503 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56625935 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55890516 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54838693 |
| 82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53787313 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53409418 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53103276 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52911466 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.52362639 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51680717 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51125730 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.50748726 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50163608 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48832296 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48210578 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48150779 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.48087489 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.45232827 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44883855 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43031067 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42905034 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42803701 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42353127 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41720624 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.41593190 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41495601 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41061471 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.40690159 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.40084735 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38592518 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37926600 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36171780 |
| 110 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36060315 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35982764 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.35468799 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35339904 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35169992 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34416049 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33539659 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33318125 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32535796 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32471696 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32471228 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31767142 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28953676 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28423679 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28381865 |
| 125 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28344886 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28013314 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27976090 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27620016 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27529565 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.26700437 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26613261 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.26359093 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25452526 |

